Alchemist Capital is an AI-native life sciences investment firm

Alchemist Capital is dedicated to science-led, data-driven investing across public and private biotech markets. We identify and back the next generation of biotech franchises, from companies advancing breakthrough medicines to those that could become category leaders with enduring, multi‑product businesses. At the core of our process is an internal AI‑native engine, used alongside fundamental research, that is designed to help make biotech diligence more systematic, repeatable, and scalable. Our team combines expertise across science, medicine, engineering, and investing. We seek to back the breakthroughs that advance human health and meaningfully improve patients’ lives.